INNOVATION PHARMACEUTICALS INC. Repayments of Notes Payable
INNOVATION PHARMACEUTICALS INC. reported Repayments of Notes Payable of $37.00 thousand for the 12-month period ending 2023-06-30, per its 10-K filed 2023-09-28.
Discontinued › Cash Flow › Financing Activities
us-gaap:RepaymentsOfNotesPayable · last filed 2023-09-28
- INNOVATION PHARMACEUTICALS INC. repayments of notes payable for the quarter ending 2023-06-30 was $25.00K.
- INNOVATION PHARMACEUTICALS INC. repayments of notes payable for the quarter ending 2023-03-31 was -$3.00K.
- INNOVATION PHARMACEUTICALS INC. repayments of notes payable for the quarter ending 2022-12-31 was $9.00K, a 99.13% decline year-over-year.
- INNOVATION PHARMACEUTICALS INC. repayments of notes payable for the quarter ending 2022-09-30 was $6.00K.
- INNOVATION PHARMACEUTICALS INC. repayments of notes payable for fiscal 2023 was $37.00K, a 96.42% decline from fiscal 2022.
- INNOVATION PHARMACEUTICALS INC. repayments of notes payable for fiscal 2022 was $1.03M, a 424.37% increase from fiscal 2021.
- INNOVATION PHARMACEUTICALS INC. repayments of notes payable for fiscal 2021 was $197.00K.
- INNOVATION PHARMACEUTICALS INC. repayments of notes payable for fiscal 2020 was $0.00.
| Period end | Repayments of Notes Payable 3 month | Repayments of Notes Payable 6 month | Repayments of Notes Payable 6 month as first filed | Repayments of Notes Payable 9 month | Repayments of Notes Payable 9 month as first filed | Repayments of Notes Payable 12 month |
|---|---|---|---|---|---|---|
| 2023-06-30 | $25.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-09-28 | $22.00K derived: sum of 2 quarters · filed 2023-09-28 | $31.00K derived: sum of 3 quarters · filed 2023-09-28 | $37.00K 10-K · filed 2023-09-28 | ||
| 2023-03-31 | -$3.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-05-15 | $6.00K derived: sum of 2 quarters · filed 2023-05-15 | $12.00K 10-Q · filed 2023-05-15 | $12.00K derived: sum of 4 quarters · filed 2023-09-28 | ||
| 2022-12-31 | $9.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-02-15 | $15.00K 10-Q · filed 2023-02-15 | $15.00K derived: sum of 3 quarters · filed 2023-09-28 | $15.00K derived: sum of 4 quarters · filed 2023-09-28 | ||
| 2022-09-30 | $6.00K 10-Q · filed 2022-11-10 | $6.00K derived: sum of 2 quarters · filed 2023-09-28 | $6.00K derived: sum of 3 quarters · filed 2023-09-28 | $1.04M derived: sum of 4 quarters · filed 2023-09-28 | ||
| 2022-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-09-28 | $0.00 derived: sum of 2 quarters · filed 2023-09-28 | $1.03M derived: sum of 3 quarters · filed 2023-09-28 | $1.03M 10-K · filed 2023-09-28 | ||
| 2022-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-05-15 | $1.03M derived: sum of 2 quarters · filed 2023-05-15 | $1.03M 10-Q · filed 2023-05-15 | $1.23M derived: sum of 4 quarters · filed 2023-05-15 | ||
| 2021-12-31 | $1.03M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-02-15 | $1.03M 10-Q · filed 2023-02-15 | $1.23M derived: sum of 3 quarters · filed 2023-02-15 | $1.23M derived: sum of 4 quarters · filed 2023-02-15 | ||
| 2021-09-30 | $0.00 10-Q · filed 2022-11-10 | $197.00K derived: sum of 2 quarters · filed 2022-11-10 | $197.00K derived: sum of 3 quarters · filed 2022-11-10 | |||
| 2021-06-30 | $197.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-09-28 | $197.00K derived: sum of 2 quarters · filed 2022-09-28 | $197.00K 10-K · filed 2022-09-28 | |||
| 2021-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-05-13 | $0.00 10-Q · filed 2022-05-13 | -$53.00K 10-Q · filed 2021-05-13 | |||
| 2020-12-31 | $0.00 10-Q · filed 2022-02-14 | -$23.00K 10-Q · filed 2021-02-22 | ||||
| 2020-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-09-27 | $0.00 derived: sum of 2 quarters · filed 2021-09-27 | $0.00 10-K · filed 2021-09-27 | |||
| 2020-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-05-13 | $0.00 10-Q · filed 2021-05-13 | ||||
| 2019-12-31 | $0.00 10-Q · filed 2021-02-22 |